Research Article
Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study
Table 1
Patients’ demographics, clinical data, and laboratory data.
| | Medians (interquartile ranges) | Frequencies | Cutoff | N | % |
| Age (years) | M: 53 ± 15† F: 59 ± 20† All: 56 ± 17† | | | | 20–59 | | 106 | 66.3 | | ≥60 | | 54 | 33.8 | |
| Sex | Female | | 40 | 25 | | Male | | 120 | 75 | |
| Diabetes | Yes | | 52 | 32.5 | | No | | 108 | 67.5 | |
| Renal failure | Yes | | 5 | 3 | | No | | 155 | 97 | |
| Pulmonary disease | Yes | | 78 | 49 | | No | | 82 | 51 | |
| Heart disease | Yes | | 43 | 28 | | No | | 109 | 72 | |
| Ferritin | 1229 (770–1853) | | | Male: 30–400 ug/L Female: 15–150 ug/L | Normal | | 6 | 4 | | Increased | | 139 | 96 | |
| D-dimer | 4 (2–12) | | | All: 0–0.55 mg/L | Normal | | 6 | 4 | | Increased | | 131 | 96 | |
| AST | 58 (29–99) | | | All: 15–37 U/L | Normal | | 50 | 32 | | Increased | | 107 | 68 | |
| ALT | 42 (27–92) | | | All: 14–36 U/L | Normal | | 103 | 66 | | Increased | | 52 | 34 | |
| ALP | 24 (20–30) | | | All: 46–120 U/L | Decreased | | 146 | 100 | | Normal | | 0 | 0 | |
| Total protein | 68 (63–71) | | | All: 64–82 g/L | Decreased | | 22 | 26 | | Normal | | 62 | 74 | |
| Bilirubin total | 13 (8–22) | | | All: 0–18.7 umol/L | Normal | | 97 | 75 | | Increased | | 32 | 25 | |
| Bilirubin nonconjugated | 6 (3–15) | | | 3.4–12 umol/L | Normal | | 38 | 30 | | Increased | | 89 | 70 | |
| Creatinine | 243 (114–508) | | | Male: 62–115 umol/L Female: 44–90 umol/L | Normal | | 56 | 38 | | Increased | | 93 | 62 | |
| BUN | 24 (9–39) | | | All: 2.6–6.4 mmol/L | Normal | | 47 | 32 | | Increased | | 102 | 68 | |
| CRP | 8 (2–13) | | | All: 0–6 mg/L | Normal | | 53 | 42 | | Increased | | 74 | 58 | |
| RBCs | 4 (3–5) | | | Male: 4.5–5.5 10^12/L Female: 3.8–4.8 10^12/L | Decreased | | 90 | 57 | | Normal | | 67 | 43 | |
| Hb | 97 (81–121) | | | Male: 130–170 g/L Female: 120–150 g/L | Decreased | | 103 | 65 | | Normal | | 55 | 35 | |
| Neutrophils | 89 (80–92) | | | 2–7 10^9/L | Normal | | 41 | 29 | | Increased | | 102 | 71 | |
| Eosinophils | 0 (0–2) | | | 0.1–0.8 10^9/L | Decreased | | 89 | 62 | | Normal | | 54 | 38 | |
| Basophils | 0 (0–0) | | | 0.02–0.1 10^9/L | Decreased | | 105 | 73 | | Increased | | 38 | 27 | |
| Monocytes | 4 (2–7) | | | 0.2–1 10^9/L | Decreased | | 35 | 24 | | Normal | | 108 | 76 | |
| Lymphocytes | 7 (4–13) | | | 1–4 10^9/L | Decreased | | 119 | 83 | | Normal | | 24 | 17 | |
| Discharge status | Cured | | 67 | 42 | | Died | | 93 | 58 | | Overall | | 160 | 100 | |
|
|
N: number of patients; M: male; F: female; all: both male and female; SD: standard deviation; BUN: blood urea nitrogen; CRP: C-reactive protein; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase. †Mean ± SD. Cutoff for laboratory tests. |